People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | — | Biotechnology | Series C | $134.9M | $2.0B | 2015 |
| Liquidia Technologies Inc | — | Biotechnology | Series B | $86.7M | $890.0M | 2018 |
| Spine Wave, Inc | — | Other Health Care | Series B | $27.4M | $117.4M | 2011 |
Seth A. Rudnick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Seth A. Rudnick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Stephen Bloch | 1 | 15 |
| Jeffrey Samberg | 1 | 14 |
| Ed Mathers | 1 | 11 |
| Clay Thorp | 1 | 10 |
| Isaac Cheng | 1 | 9 |
| Christy Shaffer | 1 | 6 |
| James W. Broderick | 1 | 5 |
| Seth Rudnick | 1 | 5 |
| Joseph DeSimone | 1 | 5 |
| Neal Fowler | 1 | 4 |
| Ralph Snyderman | 1 | 4 |
| Steve Nelson | 1 | 4 |
| Andrew D. Firlik | 1 | 3 |
| Michael K. Gutch | 1 | 2 |
| Carol Webb | 1 | 2 |
| Claudia A. Black | 1 | 2 |
| Norman Sharpless | 1 | 2 |
| Neal F Fowler | 1 | 2 |
| Thomas K Laundon | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.